Lastest from Businesswire

Subscribe to Lastest from Businesswire feed Lastest from Businesswire
Business Wire - The global leader in news distribution
Updated: 2 hours 47 min ago

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ford Motor Company (F) Investors

Fri, 08/09/2024 - 11:59
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Ford Motor Company (“Ford” or the “Company”) (NYSE: F) securities between April 27, 2022 and July 24, 2024, inclusive (the “Class Period”). Ford investors have until October 7, 2024 to file a lead plaintiff motion. Investors suffering losses on their Ford investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Applied Materials, Inc. (AMAT) on Behalf of Investors

Fri, 08/09/2024 - 11:59
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Applied Materials, Inc. (“Applied Materials” or the “Company”) (NASDAQ: AMAT) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Applied Materials investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of Investors

Fri, 08/09/2024 - 11:59
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Outset Medical, Inc. (“Outset Medical” or the “Company”) (NASDAQ: OM) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Outset investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit yo

EasyKnock Partners with Rehab Warriors to Support Veterans

Fri, 08/09/2024 - 11:59
NEW YORK--(BUSINESS WIRE)--EasyKnock, a leader in residential sale-leaseback programs, is proud to announce a strategic partnership with Rehab Warriors, an organization dedicated to training and empowering U.S. military veterans in the housing industry. This collaboration underscores EasyKnock's commitment to providing better opportunities for veterans and addressing the critical need for skilled professionals in the real estate sector. We believe Veterans deserve better, and we want to be part

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ZoomInfo Technologies Inc. (ZI) on Behalf of Investors

Fri, 08/09/2024 - 11:59
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ZoomInfo Technologies Inc. (“ZoomInfo” or the “Company”) (NASDAQ: ZI) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your ZoomInfo investments or would like to inquire about potentially pursuing claims to recover your loss under the federal secur

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of NVIDIA Corporation (NVDA) on Behalf of Investors

Fri, 08/09/2024 - 11:59
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of NVIDIA Corporation (“Nvidia” or the “Company”) (NASDAQ: NVDA) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Nvidia investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws

Columbia Seligman Premium Technology Growth Fund Announces a Third Quarter Distribution: 9.25% Annual Rate for IPO Investors

Fri, 08/09/2024 - 11:59
BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a third-quarter distribution, pursuant to its managed distribution policy, in the amount of $0.4625 per share, which is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00 offering price in the Fund’s initial public offering in November 2009. The third-quarter distribution of $0.4625 per share is equal to a quarterly rate of 1.3943% (5.58% annualized) of the F

CVC Credit prices $500m Apidos XLIX

Fri, 08/09/2024 - 11:59
NEW YORK--(BUSINESS WIRE)--CVC Credit, the $45bn global credit management business of CVC, is pleased to announce that it has successfully priced Apidos XLIX (49), a new $500m (c.€460m) Collateralized Loan Obligation ("CLO"). BNP Paribas served as lead arranger for CVC Credit’s fourth CLO pricing in North America this year. This is the eighth new CLO of the year priced by CVC globally and fourth new US CLO issue for 2024 with an aggregate value of $2bn (c.€1.8bn). Apidos XLIX has a five-year re

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Lululemon Athletica Inc. (LULU) Investors

Fri, 08/09/2024 - 11:59
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Lululemon Athletica Inc. (“Lululemon” or the “Company”) (NASDAQ: LULU) securities between December 7, 2023 and July 24, 2024, inclusive (the “Class Period”). Lululemon investors have until October 7, 2024 to file a lead plaintiff motion. Investors suffering losses on their Lululemon investments are encouraged to contact the Law Offices of Howar

NCR Voyix to Participate in Upcoming Investor Conferences

Fri, 08/09/2024 - 08:59
ATLANTA--(BUSINESS WIRE)--NCR Voyix (NYSE: VYX), leading global provider of digital commerce solutions, today announced it will participate in the following investor conferences: Oppenheimer & Co. Technology, Internet & Communications Conference Date: August 12, 2024 Location: Virtual Presenter: David Wilkinson, Chief Executive Officer Format: Fireside Chat and 1x1 and Group Investor Meetings Presentation time: 1:15 p.m. ET Needham Fintech & Digital Transformation Virtual Conference

PICit A/S Receives Strategic Growth Investment from Arcadea Group

Fri, 08/09/2024 - 08:59
AARHUS, Denmark & TORONTO & ORLANDO, Fla.--(BUSINESS WIRE)--PICit A/S, a leader in port, rail, and intermodal logistics management software, announces its strategic growth investment from Arcadea Group, a preeminent, permanent-hold investor in global software businesses. The partnership with Arcadea Group will be focused on continuing strong growth in domestic and international markets, and accelerating product development. Henrik Højen Andersen, CEO of PICit, will continue on in his role, and

Paymentus to Participate in Upcoming August Investor Conferences

Fri, 08/09/2024 - 08:59
CHARLOTTE, N.C.--(BUSINESS WIRE)--Paymentus Holdings, Inc. (“Paymentus”) (NYSE: PAY), a leading provider of cloud-based bill payment technology solutions, today announced that Dushyant Sharma, Chief Executive Officer, and Sanjay Kalra, Chief Financial Officer, are scheduled to participate in the following investor conferences: Oppenheimer Virtual Technology, Internet & Communications Conference on Wednesday, August 14th, where Mr. Sharma and Mr. Kalra will participate in a fireside chat at

AlTi Global, Inc. Reports Second Quarter 2024 Financial Results

Fri, 08/09/2024 - 08:59
NEW YORK--(BUSINESS WIRE)--AlTi Global, Inc. (NASDAQ: ALTI) (“AlTi" or the “Company”), a leading independent global wealth and alternatives manager with $72 billion in combined assets, today announced financial results for the second quarter ended June 30, 2024. A presentation of the Company’s second quarter 2024 results can be found on the Events & Presentation section of the AlTi investor relations website. Webcast and Earnings Conference Call Management will host a webcast and conference

Envestnet Reports Second Quarter 2024 Financial Results

Fri, 08/09/2024 - 08:59
BERWYN, Pa.--(BUSINESS WIRE)--Envestnet (NYSE: ENV), a leading provider of intelligent systems for wealth management and financial wellness, today reported financial results for the three and six months ended June 30, 2024.     Three months ended       Six months ended     Key Financial Metrics   June 30,   %   June 30,   % (in millions, except per share data)     2024       2023     Change     2024       2023     Change GAAP:                         Total revenue   $ 348.3     $ 312.4     11 %

Alight to Participate in the Canaccord Genuity 44th Annual Growth Conference

Fri, 08/09/2024 - 08:59
CHICAGO--(BUSINESS WIRE)--Alight (NYSE: ALIT or the “Company”), a leading cloud-based human capital technology and services provider, today announced that its President, Greg Goff, will present at the Canaccord Genuity 44th Annual Growth Conference in Boston on Tuesday, August 13, 2024 at 9 a.m. ET, available via live webcast and replay here. About Alight Solutions Alight is a leading cloud-based human capital technology and services provider for many of the world’s largest organizations. Throu

PROG Holdings, Inc. Declares Dividend

Fri, 08/09/2024 - 08:59
SALT LAKE CITY--(BUSINESS WIRE)--PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Vive Financial, Four Technologies, and Build, today announced that its Board of Directors declared a quarterly cash dividend of $0.12 per share of common stock payable on September 3, 2024, to shareholders of record on the close of business on August 20, 2024. About PROG Holdings, Inc. PROG Holdings, Inc. (NYSE:PRG) is a fintech holding company headquartered in Salt Lake City, U

Viant to Present at Upcoming Investor Conferences

Fri, 08/09/2024 - 08:59
IRVINE, Calif.--(BUSINESS WIRE)--Viant Technology Inc. (NASDAQ: DSP), a leading advertising technology company, today announced that members of its management team are scheduled to present at upcoming investor conferences. Event details are as follows: Canaccord Genuity 44th Annual Growth Conference Boston, MA Wednesday, August 14th, 2024 at 1:00 pm ET Citi 2024 Global TMT Conference New York, NY Friday, September 6th, 2024 at 9:10 am ET Available presentations will be webcast live on the inves

Pagaya and Castlelake Announce Forward Flow Agreement to Purchase up to $1 Billion of Consumer Loans Originated on the Pagaya Network

Fri, 08/09/2024 - 08:59
NEW YORK--(BUSINESS WIRE)--Pagaya Technologies LTD. (NASDAQ: PGY) ("Pagaya" or “the Company”), a global technology company delivering AI-driven product solutions for the financial ecosystem, and Castlelake, L.P. ("Castlelake"), a global alternative investment manager specializing in asset-based private credit and an experienced investor in consumer credit opportunities, today announced an agreement for Castlelake to purchase, subject to certain terms and conditions, an aggregate amount of up to

WisdomTree Announces 9% Earnings Accretive Series A Preferred Stock Repurchase and Pricing of Offering of $300 Million of Convertible Senior Notes and Related Exercise of $45 Million Greenshoe

Fri, 08/09/2024 - 08:59
NEW YORK--(BUSINESS WIRE)--WisdomTree, Inc. (NYSE: WT) (“WisdomTree”), a global financial innovator, today announced the pricing of its offering of $300 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). WisdomTree also granted the initial purchaser of the notes an option to purchase up to an additi

Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical

Fri, 08/09/2024 - 08:59
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Curon Biopharmaceutical (Curon), a privately held biotechnology company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire CN201, a novel investigational clinical-stage bispecific antibody for the treatment of B-cell associated diseases. “We continue to identify opportunities to expand and diversify o

Pages